Search
departments › ... › chiefs-message
… trusting relationships and treating our patients to the best of our abilities. Whether you seek compassionate …
research › ... › digestive-diseases-symposium
… : Saturday, Feb. 28, 2026, 8 a.m. - 3 p.m. … deadline to submit an abstract is 11:59 p.m. on Jan. 16, 2026. … you must submit a PDF of your poster by 11:59 p.m. on Jan. 26 … your printed poster with you to the symposium on Feb. 28, 2026. All submissions must adhere to the following format …
healthcare › clinical-trials › h-48387
… study in Parkinson's disease patients with dyskinesia to assess the efficacy and safety/tolerability of fixed dose combinations of JM-010 and its individual components. … The purpose of this study, which involved research, is to determine if investigational treatment, JM-010, is safe …
healthcare › clinical-trials › h-41067
… of a drug called RO7043015. RO7046015 is being developed for the possible treatment of Parkinson's disease. … antibodies are antibodies which have been engineered to recognize and bind to a specific type of protein. RO7046015 binds to a protein … PASADENA: A Study to Evaluate Intravenous RO7046015 (PRX002) in Participants …
healthcare › clinical-trials › h-49062
… multicenter, randomized, controlled pivotal trial to evaluate the safety and effectiveness of transcatheter … with the Edwards Pascal Transcatheter valve repair system compared to abbott mitraclip in patients with mitral regurgitation. … A study to evaluate transcatheter mitral valve repair with the …
news › trish-to-study-spaceflight-effects-on-genome-and-nervous-system-on-axiom-spaces-ax-3-mission
… of human health through rigorous scientific studies,” said Lucie Low, chief scientist for microgravity research at …
news › dr-maria-elena-bottazzi-dr-teresa-a-davis-elected-to-the-national-academy-of-medicine
… Tropical Medicine at Baylor College of Medicine and co-director of the Texas Children's Hospital Center for Vaccine Development , and Dr. Teresa A. Davis , … have demonstrated outstanding professional achievement and commitment to service. “Drs. Bottazzi and Davis are leaders …
healthcare › clinical-trials › h-55239
… Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major … The purpose of this study is to evaluate the safety, efficacy, and maintenance of effect …
news › breakthrough-in-human-norovirus-research-researchers-overcome-major-obstacle-to-grow-and-study-the-virus
… of acute viral gastroenteritis worldwide with severe outcomes mostly among young children, the elderly and people … has overcome a major obstacle that limited their ability to continuously grow virus, which they require to conduct … norovirus growth usually stops,” said co-author Dr. Sue Crawford , assistant professor of molecular virology and …
healthcare › clinical-trials › h-53299
… is a next-generation small molecule cardiac myosin inhibitor being developed as a chronic, oral treatment for participants with hypertrophic cardiomyopathy (HCM). … and addressing the fundamental cause of this sarcomeric disease. This is the second Phase 3 trial of …